Scinai Immunotherapeutics Ltd.

SCNI

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001611747

SEC filings (opens in a new tab)

No open-market purchases or sales by Scinai Immunotherapeutics Ltd. insiders were filed in the last 90 days; 11 institutions reported holding it in 13F filings for Q2 2026, worth $49.1K in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding Scinai Immunotherapeutics Ltd. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023 All holders in Q1 2023

13F holders of SCNI: Q1 2023 compared with Q2 2023
Measure	Q1 2023	Q2 2023	Change
Holders	11	12	+1
Shares	388.3K	220.1K	−168.3K (−43.3%)
Value	$838.9K	$309.0K	−$529.9K (−63.2%)

New holders (2)

Institutions that held Scinai Immunotherapeutics Ltd. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to SCNI in Q2 2023
Institution	Shares	Value	% of portfolio
Susquehanna International Group, LLP	10,921	$14.9K	0.00%
Rhumbline Advisers	3,499	$4.76K	0.00%

Sold out (1)

Institutions that held Scinai Immunotherapeutics Ltd. at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of SCNI in Q2 2023
Institution	Shares, Q1 2023	Value, Q1 2023
Virtu Financial LLC	10,508	$23.0K